Login

Houlihan Lokey CEO Scott Beiser celebrates the firm's IPO at the NYSE, discussing M&A activity and key trends in restructuring. 00:10:00

Share On Facebook Share On Twitter

Scott Beiser is a Co-Chairman of Houlihan Lokey

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Sanjeev Verma on Black Box: The Preferred Partner for Digital Infrastructure | Sanjeev Verma, CEO, Black Box Ltd.
00:10:00
Pegasystems, led by CEO Alan Trefler, has been making significant strides since transitioning to cloud services.|Alan Trefler is the Founder and CEO of Pegasystems Inc.,
00:10:00
Navigating COVID-19 and Expanding Horizons: Aritzia CEO Brian Hill's Vision | Brian Hill, CEO, Aritzia.
00:10:00
backing global entrepreneurs in the field of information technology|Eduardo Saverin,Co-Founder and Partner,B Capital Group
00:10:00
AAK AB Q3 2023 Report: Insights from CEO Johan Westman | Johan Westman, CEO , AAK AB.
00:10:00
BBVA Reports Strong Financial Performance and Strategic Expansion | Onur Genç , CEO , BBVA .
00:10:00
Perspectives from Activist Investor Bill Ackman
00:10:00
Goodwell Investments is a pioneering impact investment firm focused on inclusive growth|Wim Van Der Beek,Founder and Managing Partner,Goodwell Investments
00:10:00
Bridging the Investing and Net Worth Gender Gap: Insights from Mary Beth Storjohann, CFP®
00:10:00
Fundsmith CEO Terry Smith shares his approach to technology investments amid the ongoing tech sector boom with Canaccord Genuity Wealth.
00:10:00
How Ban Leong become one of Singapore’s leading electronic distributors|Managing director , Ban Leong Technologies Ltd
00:10:00
"Lazard Asset Management hosts an insightful summit on family offices and asset management, facilitating strategic discussions and networking opportunities."|Evan L. Russo became Chief Executive Officer of Lazard's Asset Management

© 2017 - Neuhu+